Surface Refractive Index Shift and Lens Absorption/Adsorption of Tear Components of Kalifilcon A Lenses vs Dailies Total1 and Precision1
NCT ID: NCT04840563
Last Updated: 2021-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2021-04-07
2021-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Surface Refractive Index Shift of Kalifilcon A Lenses Compared to Dailies Total 1, Precision 1 and Biotrue ONEday Lenses
NCT04555031
Product Performance of a New Silicone Hydrogel Contact Lens
NCT04901897
DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study
NCT06483113
ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®
NCT02750813
Kalifilcon A Toric Compared to Commercially Available Lenses
NCT06098937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Kalifilcon A lenses
Commercially available kalifilcon A lenses (Bausch + Lomb)
Kalifon A
Commercially available kalifilcon A lenses
Dailies Total1
Dailies Total1 (Alcon)
Dailies Total1
Dailies Total1
Precision1
Precision1 (Alcon)
Precision1
Precision1
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kalifon A
Commercially available kalifilcon A lenses
Dailies Total1
Dailies Total1
Precision1
Precision1
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
3. Have no active ocular disease or allergic conjunctivitis.
4. Not be using any topical ocular medications.
5. Be willing and able to follow instructions.
6. Have signed a statement of informed consent.
Exclusion Criteria
2. Considered by the Investigator to not be a suitable candidate for participation.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffery Schafer, OD
Role: PRINCIPAL_INVESTIGATOR
Bausch & Lomb Incorporated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bausch Site 001
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ROC2-21-007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.